Studio delle lesioni focali epatiche. Confronto tra risonanza magnetica in condizioni di base e dopo mezzo di contrasto superparamagnetico

Translated title of the contribution: Unenhanced versus Spio-enhanced MRI in the evaluation of focal liver lesions

Mario Finazzo, Massimo Midiri, Cristina Gallo, Tommaso Vincenzo Bartolotta, Angelo Luca

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Introduction. Superparamagnetic iron oxide (Spio) is a negative contrast material which is phagocytosed by reticuloendothelial cells. It significantly decreases the signal intensity of the organs where it is taken up selectively, especially on T2-weighted images. According to previous reports, it improves the visualization of focal liver lesions with(out) a low content of Kupffer's cells. We investigated the yield of Spio-enhanced MRI in the detection and characterization of focal liver lesions. Materials and methods. Eighteen patients underwent MRI before and after the administration of Spio particles. T1, PD, T2 SE and T2* GE images were acquired with a .5 T superconductive unit. The Spio dose was .075 mL/kg which was administered i.v. in 35-45 minutes' infusions. Images were acquired about 30-90 minutes after the end of administration. Scanning was repeated in one patient about 8 hours after the end of Spio administration. Results. Baseline MRI showed hepatocellular carcinoma (HCC) in 10 patients, metastases in 4, 1 dysplastic lesion, 1 single and 1 multiple hemangioma, 1 focal nodular hyperplasia (FNH) and 1 intrahepatic cholangiocarcinoma. No lesion was detected in one patient. spio-enhanced MRI detected 7 more lesions that baseline MRI, with 11.47% sensitivity improvement. Moreover, Spio-enhanced MRI detected more lesions that baseline MRI in 5/18 patients (27.78%). PD/T2 SE images were the most sensitive ones, followed by T2* Ge and finally by T1 SE. Nearly all HCC nodules (17/18), all metastatic lesions and the cholangiocarcinoma did not take up iron oxide and were relatively hyperintense to the liver. However, in one well-differentiated HCC, the nodule partially took up the contrast agent and became isointense, with high-signal borders of PD/T2 SE images. Both the dysplastic lesion and FNH took up iron oxide; the former was isointense to the liver, while the latter appeared slightly hyperintense, with a high- signal central scar. Finally, hemangiomas became hyperintense on Spio- enhanced T1 SE images and had slightly decreased signal intensity on Spio- enhanced T2 SE images. Conclusions. In our experience iron oxide was an effective contrast material. Spio-enhanced MRI improved the detection and characterization of focal liver lesions relative to baseline MRI. Several liver-specific contrast agents are now available or in an advanced experimental stage. Therefore, future studies could be aimed at assessing the effectiveness of iron oxide versus other contrast agents and at establishing the role of Spio-enhanced MRI versus spiral CT and CT during arterial portography.

Original languageItalian
Pages (from-to)599-607
Number of pages9
JournalRadiologia Medica
Volume95
Issue number6
Publication statusPublished - Jun 1998

Fingerprint

Liver
Contrast Media
Focal Nodular Hyperplasia
Hepatocellular Carcinoma
Cholangiocarcinoma
Hemangioma
ferric oxide
Portography
Cytophagocytosis
Kupffer Cells
Spiral Computed Tomography
Cicatrix
Neoplasm Metastasis

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging

Cite this

Studio delle lesioni focali epatiche. Confronto tra risonanza magnetica in condizioni di base e dopo mezzo di contrasto superparamagnetico. / Finazzo, Mario; Midiri, Massimo; Gallo, Cristina; Bartolotta, Tommaso Vincenzo; Luca, Angelo.

In: Radiologia Medica, Vol. 95, No. 6, 06.1998, p. 599-607.

Research output: Contribution to journalArticle

Finazzo, Mario ; Midiri, Massimo ; Gallo, Cristina ; Bartolotta, Tommaso Vincenzo ; Luca, Angelo. / Studio delle lesioni focali epatiche. Confronto tra risonanza magnetica in condizioni di base e dopo mezzo di contrasto superparamagnetico. In: Radiologia Medica. 1998 ; Vol. 95, No. 6. pp. 599-607.
@article{f15d190684d44f2aafef001caf6821d7,
title = "Studio delle lesioni focali epatiche. Confronto tra risonanza magnetica in condizioni di base e dopo mezzo di contrasto superparamagnetico",
abstract = "Introduction. Superparamagnetic iron oxide (Spio) is a negative contrast material which is phagocytosed by reticuloendothelial cells. It significantly decreases the signal intensity of the organs where it is taken up selectively, especially on T2-weighted images. According to previous reports, it improves the visualization of focal liver lesions with(out) a low content of Kupffer's cells. We investigated the yield of Spio-enhanced MRI in the detection and characterization of focal liver lesions. Materials and methods. Eighteen patients underwent MRI before and after the administration of Spio particles. T1, PD, T2 SE and T2* GE images were acquired with a .5 T superconductive unit. The Spio dose was .075 mL/kg which was administered i.v. in 35-45 minutes' infusions. Images were acquired about 30-90 minutes after the end of administration. Scanning was repeated in one patient about 8 hours after the end of Spio administration. Results. Baseline MRI showed hepatocellular carcinoma (HCC) in 10 patients, metastases in 4, 1 dysplastic lesion, 1 single and 1 multiple hemangioma, 1 focal nodular hyperplasia (FNH) and 1 intrahepatic cholangiocarcinoma. No lesion was detected in one patient. spio-enhanced MRI detected 7 more lesions that baseline MRI, with 11.47{\%} sensitivity improvement. Moreover, Spio-enhanced MRI detected more lesions that baseline MRI in 5/18 patients (27.78{\%}). PD/T2 SE images were the most sensitive ones, followed by T2* Ge and finally by T1 SE. Nearly all HCC nodules (17/18), all metastatic lesions and the cholangiocarcinoma did not take up iron oxide and were relatively hyperintense to the liver. However, in one well-differentiated HCC, the nodule partially took up the contrast agent and became isointense, with high-signal borders of PD/T2 SE images. Both the dysplastic lesion and FNH took up iron oxide; the former was isointense to the liver, while the latter appeared slightly hyperintense, with a high- signal central scar. Finally, hemangiomas became hyperintense on Spio- enhanced T1 SE images and had slightly decreased signal intensity on Spio- enhanced T2 SE images. Conclusions. In our experience iron oxide was an effective contrast material. Spio-enhanced MRI improved the detection and characterization of focal liver lesions relative to baseline MRI. Several liver-specific contrast agents are now available or in an advanced experimental stage. Therefore, future studies could be aimed at assessing the effectiveness of iron oxide versus other contrast agents and at establishing the role of Spio-enhanced MRI versus spiral CT and CT during arterial portography.",
keywords = "Focal liver lesions, MRI, Focal liver lesions, supermagnetic iron oxide, Liver, focal lesions",
author = "Mario Finazzo and Massimo Midiri and Cristina Gallo and Bartolotta, {Tommaso Vincenzo} and Angelo Luca",
year = "1998",
month = "6",
language = "Italian",
volume = "95",
pages = "599--607",
journal = "Radiologia Medica",
issn = "0033-8362",
publisher = "Springer-Verlag Italia s.r.l.",
number = "6",

}

TY - JOUR

T1 - Studio delle lesioni focali epatiche. Confronto tra risonanza magnetica in condizioni di base e dopo mezzo di contrasto superparamagnetico

AU - Finazzo, Mario

AU - Midiri, Massimo

AU - Gallo, Cristina

AU - Bartolotta, Tommaso Vincenzo

AU - Luca, Angelo

PY - 1998/6

Y1 - 1998/6

N2 - Introduction. Superparamagnetic iron oxide (Spio) is a negative contrast material which is phagocytosed by reticuloendothelial cells. It significantly decreases the signal intensity of the organs where it is taken up selectively, especially on T2-weighted images. According to previous reports, it improves the visualization of focal liver lesions with(out) a low content of Kupffer's cells. We investigated the yield of Spio-enhanced MRI in the detection and characterization of focal liver lesions. Materials and methods. Eighteen patients underwent MRI before and after the administration of Spio particles. T1, PD, T2 SE and T2* GE images were acquired with a .5 T superconductive unit. The Spio dose was .075 mL/kg which was administered i.v. in 35-45 minutes' infusions. Images were acquired about 30-90 minutes after the end of administration. Scanning was repeated in one patient about 8 hours after the end of Spio administration. Results. Baseline MRI showed hepatocellular carcinoma (HCC) in 10 patients, metastases in 4, 1 dysplastic lesion, 1 single and 1 multiple hemangioma, 1 focal nodular hyperplasia (FNH) and 1 intrahepatic cholangiocarcinoma. No lesion was detected in one patient. spio-enhanced MRI detected 7 more lesions that baseline MRI, with 11.47% sensitivity improvement. Moreover, Spio-enhanced MRI detected more lesions that baseline MRI in 5/18 patients (27.78%). PD/T2 SE images were the most sensitive ones, followed by T2* Ge and finally by T1 SE. Nearly all HCC nodules (17/18), all metastatic lesions and the cholangiocarcinoma did not take up iron oxide and were relatively hyperintense to the liver. However, in one well-differentiated HCC, the nodule partially took up the contrast agent and became isointense, with high-signal borders of PD/T2 SE images. Both the dysplastic lesion and FNH took up iron oxide; the former was isointense to the liver, while the latter appeared slightly hyperintense, with a high- signal central scar. Finally, hemangiomas became hyperintense on Spio- enhanced T1 SE images and had slightly decreased signal intensity on Spio- enhanced T2 SE images. Conclusions. In our experience iron oxide was an effective contrast material. Spio-enhanced MRI improved the detection and characterization of focal liver lesions relative to baseline MRI. Several liver-specific contrast agents are now available or in an advanced experimental stage. Therefore, future studies could be aimed at assessing the effectiveness of iron oxide versus other contrast agents and at establishing the role of Spio-enhanced MRI versus spiral CT and CT during arterial portography.

AB - Introduction. Superparamagnetic iron oxide (Spio) is a negative contrast material which is phagocytosed by reticuloendothelial cells. It significantly decreases the signal intensity of the organs where it is taken up selectively, especially on T2-weighted images. According to previous reports, it improves the visualization of focal liver lesions with(out) a low content of Kupffer's cells. We investigated the yield of Spio-enhanced MRI in the detection and characterization of focal liver lesions. Materials and methods. Eighteen patients underwent MRI before and after the administration of Spio particles. T1, PD, T2 SE and T2* GE images were acquired with a .5 T superconductive unit. The Spio dose was .075 mL/kg which was administered i.v. in 35-45 minutes' infusions. Images were acquired about 30-90 minutes after the end of administration. Scanning was repeated in one patient about 8 hours after the end of Spio administration. Results. Baseline MRI showed hepatocellular carcinoma (HCC) in 10 patients, metastases in 4, 1 dysplastic lesion, 1 single and 1 multiple hemangioma, 1 focal nodular hyperplasia (FNH) and 1 intrahepatic cholangiocarcinoma. No lesion was detected in one patient. spio-enhanced MRI detected 7 more lesions that baseline MRI, with 11.47% sensitivity improvement. Moreover, Spio-enhanced MRI detected more lesions that baseline MRI in 5/18 patients (27.78%). PD/T2 SE images were the most sensitive ones, followed by T2* Ge and finally by T1 SE. Nearly all HCC nodules (17/18), all metastatic lesions and the cholangiocarcinoma did not take up iron oxide and were relatively hyperintense to the liver. However, in one well-differentiated HCC, the nodule partially took up the contrast agent and became isointense, with high-signal borders of PD/T2 SE images. Both the dysplastic lesion and FNH took up iron oxide; the former was isointense to the liver, while the latter appeared slightly hyperintense, with a high- signal central scar. Finally, hemangiomas became hyperintense on Spio- enhanced T1 SE images and had slightly decreased signal intensity on Spio- enhanced T2 SE images. Conclusions. In our experience iron oxide was an effective contrast material. Spio-enhanced MRI improved the detection and characterization of focal liver lesions relative to baseline MRI. Several liver-specific contrast agents are now available or in an advanced experimental stage. Therefore, future studies could be aimed at assessing the effectiveness of iron oxide versus other contrast agents and at establishing the role of Spio-enhanced MRI versus spiral CT and CT during arterial portography.

KW - Focal liver lesions, MRI

KW - Focal liver lesions, supermagnetic iron oxide

KW - Liver, focal lesions

UR - http://www.scopus.com/inward/record.url?scp=0031773149&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031773149&partnerID=8YFLogxK

M3 - Articolo

C2 - 9717542

AN - SCOPUS:0031773149

VL - 95

SP - 599

EP - 607

JO - Radiologia Medica

JF - Radiologia Medica

SN - 0033-8362

IS - 6

ER -